Bigul

SICAGEN INDIA LTD. - 533014 - Submission Of Audited Financial Results For The Quarter And Year Ended 31 Mar'' 2021

The Board of Directors of the Company at its meeting held today, has inter alia considered and approved the following 1) Audited financial results for the quarter and year ended 31st March 2021. 2) Recommendation of equity dividend @ 5% (Re.0.50 per share) for the year 2020-21 subject to approval of shareholders at the ensuing AGM. 3) Proposal for delisting of equity shares from NSE has been reconsidered.
26-05-2021
Bigul

SICAGEN INDIA LTD. - 533014 - Board Meeting Intimation for Consideration And Approval Of Audited Financial Results And Audited Financial Statements For The Year Ended 31St March, 2021 & To Consider The Recommendation Of Final Dividend For The Year Ended 31St March, 2021

SICAGEN INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2021 ,inter alia, to consider and approve This is to inform that, a meeting of the Board of Directors of the Company will be held on Wednesday, 26th May, 2021 inter alia : i. To consider and approve the Audited financial results (both Standalone & Consolidated) of the Company for the quarter and year ended 31st March, 2021. ii. To consider and approve the Audited Financial Statements (both Standalone & Consolidated) of the Company for the year ended 31st March, 2021. iii. To consider and Recommend Final dividend for the financial year 2020-21. As intimated earlier vide our letter dated 31st March 2021, the trading window for dealing in the Company's equity shares by the Designated persons and their immediate relatives will remain closed from 01st April 2021 till 48 hours after the declaration of Audited Financial Results for the quarter and year ended 31st March, 2021, as per Company's Code of Conduct to regulate, monitor and report trading by insiders, read with SEBI (Prohibition of Insider Trading) Regulations, 2015.
18-05-2021
Bigul

SICAGEN INDIA LTD. - 533014 - Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half Year Ended 31St March, 2021

Certificate under Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the half year ended 31st March, 2021
20-04-2021
Bigul

SICAGEN INDIA LTD. - 533014 - Shareholding for the Period Ended March 31, 2021

Sicagen India Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2021. For more details, kindly Click here
08-04-2021
Bigul

SICAGEN INDIA LTD. - 533014 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Compliance Certificate under Regulation 74 (5) of SEBI (DP) Regulations, 2018 for the Quarter ended 31st March 2021
07-04-2021
Bigul

SICAGEN INDIA LTD. - 533014 - Compliance Certificate Under Regulation 7(3) Of SEBI (LODR) Regulations, 2015 For The Half-Year Ended 31St March 2021

Compliance Certificate under Regulation 7(3) of SEBI (LODR) Regulations, 2015 for the Half-year ended 31st March 2021
07-04-2021
Bigul

Sicagen India Ltd - 533014 - Statement Of Investor Complaints For The Quarter Ended March 2021

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0110 Name of the Signatory :- R SrikrishnaDesignation :- Company Secretary and Compliance Officer
07-04-2021
Bigul

Sicagen India Ltd - 533014 - Closure of Trading Window

This is to inform that, the Trading Window for dealing in Company's securities by the Designated persons and their immediate relatives will remain closed from April 01, 2021 till 48 hours after the declaration of Audited Financial Results for the quarter and year ended March 31, 2021, as per the Company's 'Code of Conduct to regulate, monitor and report trading by the Designated persons and their immediate relatives' adopted by the Board pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.
31-03-2021
Bigul

Sicagen India Ltd - 533014 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Sicagen India Limited has informed the Exchange about Loss of Share Certificates
26-03-2021
Next Page
Close

Let's Open Free Demat Account